OBJECTIVE: Gynaecological oncological surgery (GOS) includes a wide variety of surgical procedures and postoperative pain is a major concern. This study compared the impact of intrathecal morphine (ITM) plus patient-controlled analgesia (PCA) with PCA alone on morphine consumption, pain relief and patient satisfaction after GOS. METHODS: Sixty women undergoing GOS under general anaesthesia were randomized to receive either 0.3 mg ITM or placebo. On arrival at the postanaesthesia care unit each patient received a morphine PCA pump. The three primary outcome measures were pain, patient satisfaction scores evaluated using a 100-mm visual analogue scale and cumulative PCA morphine consumption. RESULTS: No significant differences were observed in the demographic data. Cumulative PCA morphine consumption was significantly lower in the ITM group compared with the control group. Fatigue scores were lower in the ITM group compared with the control group but did not reach statistical significance. Pain, sedation and patient satisfaction scores, and the rate of sideeffects were similar for the two groups. CONCLUSIONS: Administering ITM in GOS could improve postoperative analgesia and reduce morphine consumption without serious side-effects.
Introduction
Good pain control after major abdominal surgery is one of the most important factors for reducing hospital stay and increasing patient comfort and satisfaction. 1 Compared with benign gynaecological procedures, gynaecological oncological surgery (GOS) is associated with larger abdominal incisions, more extensive dissections and a more pronounced inflammatory response with a potentially more challenging pain profile. 2 Postoperative pain resulting from GOS, including cytoreductive surgery, is often underestimated and is usually managed in I Kara, S Apiliogullari, B Oc et al. Intrathecal morphine for pain management after GOS the same way as it is for benign abdominal procedures. 1, 2 Patient-controlled analgesia (PCA) is an effective method of postoperative pain management and offers more advantages than conventional techniques. 3 Nevertheless, despite being on PCA, some patients still experience postoperative pain and PCArelated side-effects. 4 The introduction of intrathecal opioids has been one of the most important breakthroughs in pain management in the last two decades. 5 In a study by Karaman et al., 6 intrathecal morphine (ITM) without local anaesthetic was very effective in reducing postoperative pain and also decreased systemic morphine consumption in patients undergoing simple abdominal hysterectomy for benign conditions with general anaesthesia.
Evaluation of the effectiveness of ITM on PCA morphine consumption, and on postoperative pain and satisfaction scores, in patients undergoing GOS has to our knowledge not previously been undertaken in a randomized trial. The present study compared the effects of ITM and PCA with PCA alone on pain relief, patient satisfaction and morphine consumption in women undergoing GOS under general anaesthesia. 
Patients and methods

STUDY POPULATION
STUDY PROCEDURES
Patients were randomized by sealed envelope assignment to receive either 0.3 mg ITM (ITM group) or placebo (control group). In the ITM group, the same anaesthesiologist (I.K.) performed lumbar punctures in the sitting position at the L 3 -L 4 or L 4 -L 5 lumbar vertebral level with a 27G pencil point spinal needle. For the control group, the skin was punctured with a 27G dental needle without any medication, but the needle was not advanced beyond the subcutaneous tissue. This was performed by the same anaesthesiologist (I.K.) who was not involved in the study evaluation. Monitoring and anaesthesia were standardized. Anaesthesia was induced with 2 mg/kg propofol, 2 µg/kg fentanyl and 0.6 mg/kg rocuronium, all administered intravenously. After tracheal intubation, anaesthesia was maintained with a mixture of air (0.5 l/min) and oxygen (0.5 l/min) plus desflurane (4 -6%). On arrival at the postanaesthesia care unit (PACU), each patient received a PCA pump programmed to deliver an initial morphine bolus of 0.05 mg/kg if their pain score was > 60 on a 100-mm visual analogue scale (VAS; 0 mm, no pain; 100 mm worst pain imaginable). On discharge from the PACU, the pump was reprogrammed to deliver a morphine bolus of 1.5 mg with a 7-min lockout without base flow. 7 PCA was maintained during the first 48-h postoperative period.
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PRIMARY AND SECONDARY OUTCOME MEASURES
The three primary outcome measures were pain scores (0 -100 mm VAS; defined as above), patient satisfaction scores (0 -100 mm VAS; 0 mm very unsatisfied; 100 mm very satisfied), and cumulative PCA morphine consumption (mg). Secondary outcomes were side-effects including nausea, vomiting, pruritus, sedation, fatigue, and respiratory depression. Data were recorded postoperatively by the same trained nursing staff at 30 min and at 1, 3, 6, 12, 24 and 48 h. Patients were directly asked if they had experienced any nausea, vomiting or pruritus during the study. Intravenous antiemetics were administered (4 mg ondansetron and 20 mg diphenhydramine hydrochloride) as rescue drugs at the patient's request. The numbers of patients with nausea, vomiting or pruritus and the number of patients requiring rescue medication were recorded. Sedation was assessed using a five-point scoring scale: 0, fully awake; 1, drowsy, closed eyes; 2, asleep but easily aroused with light tactile stimulation or simple verbal command; 3, asleep and aroused only by strong physical stimulation; and 4, could not be aroused. Fatigue was assessed on a four-point categorical scale: 0, none; 1, mild; 2, moderate; and 3, severe. Respiratory depression was defined as a respiratory rate < 10 breaths/min and was reversed by administering 0.1 mg naloxone intravenously, repeated every 5 min until adequate respiration was restored.
STATISTICAL ANALYSES
In a pilot study, 20 patients scheduled for elective GOS under general anaesthesia consumed a mean ± SD of 57 ± 21 mg of morphine in the first 48 h with a PCA pump. To achieve a one-third reduction of opioid consumption with α error of 0.005 and power of 90%, the study needed 26 patients in each group.
The SPSS ® statistical package, version 16.0 for Windows ® (SPSS Inc., Chicago, IL, USA) was used for statistical analysis. Data were expressed as mean ± SD and number (%) of patients and were tested for normality using the Kolmogorov-Smirnov normality test. For categorical variables, the data were analysed using the χ 2 -test. For continuous variables, the Student's t-test was used for normally distributed data and the Mann-Whitney Utest for non-normally distributed data. A Pvalue < 0.05 was considered to be statistically significant.
Results
This study included 60 patients, aged 18 -65 years, scheduled for GOS under general anaesthesia and randomized into two groups of 30 patients. Two patients from the ITM group and two from the control group were excluded because of technical problems with the PCA machine and missing data, respectively. The groups were comparable with respect to age, weight, height, duration of surgery and type of malignancy (Table 1) .
Patients in the ITM group had significantly lower cumulative morphine consumption than the control group during the 48-h postoperative period (P < 0.001 at all time points; Table 1 ). Table 2 shows the results for the other primary outcomes and for the secondary outcomes. Pain scores, patient satisfaction scores and sedation scores were comparable in both groups at all times. Overall mean patient satisfaction scores were 59.3 ± 4.3 and 57.5 ± 3.1 for the ITM and control groups, respectively; there was no difference between the ITM and control group. More patients had lower fatigue scores in the ITM group than in the I Kara, S Apiliogullari, B Oc et al. Intrathecal morphine for pain management after GOS control group, but the difference was not statistically significant. There were no statistically significant differences between the two groups in rates of nausea and pruritis at any time postoperatively. Nausea was observed in 13/28 patients in the ITM group and 10/28 patients in the control group (not statistically significant). Pruritis was observed in 4/28 patients in the ITM group and 0/28 patients in the control group (not statistically significant).
Discussion
The present study showed that ITM significantly reduced cumulative PCA morphine consumption without causing a significant difference in pain and satisfaction scores or the rate of side-effects in patients undergoing GOS with general anaesthesia.
A wide variety of surgical procedures are involved in GOS including radical hysterectomy, pelvic para-aortic lymphadenectomy, upper abdominal procedures and bowel resection. 2 Severe postoperative pain is a major concern in these patients. Pain has significant effects on multiple systems and induces physiological, immunological and psychological changes. 8, 9 Nausea and fatigue are two important factors affecting patient satisfaction in those undergoing abdominal hysterectomy. PCA with intravenous opioids, such as morphine, has been considered the gold standard method for pain management following major abdominal surgery as it provides superior pain control compared with conventional opioid analgesia. 4,5,10 PCA allows for better titration to optimize postoperative pain management, minimize adverse effects and reduce postoperative complications and recovery time. 5 5, 11 New ways to decrease systemic morphine-related sideeffects are being sought. 11, 12 Use of ITM is a simple and quick procedure that is expected to decrease postoperative pain intensity and opioid requirements and accelerate recovery. 13 The ITM dose for major abdominal surgery varies widely. For gynaecological surgery, the results of Rodanant et al. 14 showed that 0.2 mg ITM produced adequate analgesia and fewer sideeffects in women undergoing abdominal hysterectomy under spinal anaesthesia. These authors also reported that there was no advantage in increasing the dose in terms of efficacy but that higher doses led to an increase in the number of pruritic patients who required treatment. 14 6 showed that 0.5 mg ITM reduced PCA morphine consumption and enhanced the quality of postoperative analgesia in women undergoing abdominal hysterectomy. Also, nausea and pruritus were less frequently observed in the ITM group. 6 The lower dose of 0.3 mg ITM was selected over higher doses in the present study and combined with postoperative PCA morphine.
In the present study, morphine consumption was reduced by approximately three-fold in the ITM group compared with the control group. Compared with the study reported by Karaman et al., 6 fewer patients in the ITM group in the present study experienced nausea, although this still amounted to nearly half of the patients (13/28 patients). This may be related to the lower dose of ITM administered in the current study (0.3 versus 0.5 mg, respectively) and indicates a need for prophylactic antiemetics.
More patients in the ITM group in the present study had lower postoperative fatigue scores compared with the control group (although the difference was not statistically significant). Reduced fatigue probably has multifactorial reasons, resulting from interactions between biological, psychological and, possibly, social factors, which makes it difficult to prevent and treat. 16 The physiological response to surgical trauma (i.e. the surgical stress response) can be controlled with neuraxial opioids. 17, 18 Further research is needed to clarify the risk-benefit ratio of ITM compared with PCA morphine.
One of the major concerns regarding both ITM and PCA morphine is its safety with respect to respiratory depression and other side-effects. Some authors have used neuraxial morphine with parenteral narcotic in the postoperative period. 7, 19 One study used 0.5 mg morphine combined with PCA after a liver resection without adverse outcomes. 7 Respiratory depression may be increased when intravenous morphine and ITM are combined. Thus, the PCA pump in the present study was programmed for a morphine bolus of 1.5 mg without base flow. It is not possible to predict, however, when respiratory depression will occur. 20 In conclusion, the addition of ITM to PCA morphine significantly reduced cumulative PCA morphine consumption over a 48-h postoperative period in GOS patients, with no obvious increase in pain, reduction in patient satisfaction or increase in the rate of adverse effects compared with PCA morphine alone. Nevertheless, patient satisfaction scores were < 60 for the majority of patients, indicating that overall patient satisfaction was not high and there is, therefore, a need for further research in order
